secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0000950170-24-059624
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q1 revenue down 14% to $11.8M; net loss widens; strategic review ongoing after deal collapse
--------------------------------------------------------------------------------

- Q1 revenue $11.8M vs $13.7M YoY; net loss $3.5M ($0.21/share) vs $2.1M ($0.13/share).
- Cyclo G6 revenue $3.0M (down 19% YoY); system sales fell to 22 units from 61.
- Retina product revenue $6.8M, down 6% YoY; gross margin contracted to 37.9% from 43.3%.
- Cash $5.4M as of March 30, 2024; used $1.6M in the quarter.
- First expected asset sale terminated; strategic review continues with multiple parties on product lines or whole company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017024059624/0000950170-24-059624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017024059624/irix-20240514.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-059624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer